Arena Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid
Arena Pharmaceuticals, Inc. had Lessee, Operating Lease, Liability, to be Paid of $12.00 million as of 2021-12-31, per its 10-K filed 2022-02-23.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2022-02-23
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid $12.00M.
- 2020-12-31: Lessee, Operating Lease, Liability, to be Paid $14.54M.
- 2019-12-31: Lessee, Operating Lease, Liability, to be Paid $16.80M.
- 2019-09-30: Lessee, Operating Lease, Liability, to be Paid $17.37M.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2021-12-31 | $12.00M 10-K · filed 2022-02-23 |
| 2020-12-31 | $14.54M 10-K · filed 2021-02-23 |
| 2019-12-31 | $16.80M 10-K · filed 2020-02-27 |
| 2019-09-30 | $17.37M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $10.31M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $8.61M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $8.85M 10-Q · filed 2019-11-08 |